Hospital
Medical University Hospital Authority
Medical University Hospital Authority was paid $4.96M by Medicaid between Mar 2019 and Dec 2024, across 141 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 22% of everything it billed.
33Billing provider infoMEDICAL UNIVERSITY HOSPITAL AUTHORITY
CHESTER, SC 29706
CHESTER, SC 29706
33aNPI1437622933assigned 01/07/2019
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.96M
24GClaims211,794
24DCodes billed141
24AFirst – last monthMar 2019 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in South Carolina
Rank by total paid#50 of 115
Median peer was paid$2.47M
This provider vs. median2.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RAE, KARYN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 41,028 | $1.06M | |
| 2020 | 28,593 | $580K | |
| 2021 | 33,432 | $606K | |
| 2022 | 43,288 | $1.02M | |
| 2023 | 34,934 | $1.11M | |
| 2024incomplete | 30,519 | $585K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 22% | 13,772 | 11,353 | $1.08M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 12% | 4,729 | 4,348 | $615K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 8.0% | 3,294 | 3,122 | $396K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.2% | 14,189 | 11,851 | $356K |
| 80048 | Basic metabolic panel (calcium, ionized) | 5.4% | 3,235 | 2,768 | $267K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.4% | 6,419 | 4,895 | $216K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4.2% | 2,222 | 1,655 | $210K |
| 81001 | 3.9% | 9,891 | 8,487 | $194K | |
| 36415 | Collection of venous blood by venipuncture | 3.1% | 13,184 | 10,291 | $155K |
| 81025 | 2.6% | 3,948 | 3,687 | $129K | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.2% | 11,074 | 9,771 | $108K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1.8% | 3,302 | 2,701 | $88K |
129 more codes
| J2550 | Injection, promethazine hcl, up to 50 mg | 1.4% | 1,260 | $69K |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 2,928 | $64K |
| 87081 | 1.2% | 721 | $59K | |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 1,840 | $54K |
| 87400 | <1% | 1,091 | $49K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,731 | $43K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 797 | $42K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,513 | $41K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,001 | $41K |
| 82947 | <1% | 1,311 | $40K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 506 | $34K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 401 | $31K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,940 | $30K |
| 73610 | <1% | 343 | $28K | |
| 99285 | Emergency room visit (most serious) | <1% | 5,847 | $27K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 966 | $27K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 260 | $25K |
| 86803 | <1% | 347 | $21K | |
| 87070 | <1% | 428 | $21K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,200 | $18K |
| 87077 | <1% | 665 | $17K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,797 | $16K |
| 81003 | <1% | 896 | $16K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 374 | $16K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,165 | $16K |
| 87807 | <1% | 248 | $15K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,303 | $15K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,363 | $14K |
| 84703 | <1% | 317 | $14K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 122 | $14K |
| 73630 | <1% | 258 | $14K | |
| 96376 | <1% | 796 | $13K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 80 | $13K |
| 73560 | <1% | 212 | $11K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 248 | $11K |
| 85027 | <1% | 3,234 | $10K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,227 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,244 | $9K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 179 | $9K |
| 80061 | Lipid panel | <1% | 777 | $9K |
| 87430 | <1% | 535 | $9K | |
| 84484 | <1% | 6,219 | $8K | |
| 93971 | <1% | 40 | $8K | |
| 85379 | <1% | 1,204 | $8K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,400 | $7K |
| 86710 | <1% | 88 | $7K | |
| 84702 | <1% | 100 | $5K | |
| 85610 | <1% | 2,418 | $5K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 97 | $5K |
| 73030 | <1% | 89 | $5K | |
| 0002A | <1% | 89 | $5K | |
| 99460 | <1% | 50 | $4K | |
| 0001A | <1% | 84 | $4K | |
| 87040 | <1% | 1,882 | $4K | |
| 85007 | <1% | 1,417 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,002 | $3K |
| 86900 | <1% | 26 | $3K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 38 | $3K |
| 72100 | <1% | 108 | $2K | |
| 82962 | <1% | 65 | $2K | |
| 83605 | <1% | 2,281 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,597 | $2K |
| 87800 | <1% | 29 | $2K | |
| 73130 | <1% | 26 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 162 | $1K |
| 87420 | <1% | 45 | $1K | |
| 97161 | <1% | 149 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,098 | $1K |
| 82550 | <1% | 1,457 | $1K | |
| 73562 | <1% | 16 | $1K | |
| 87186 | <1% | 337 | $1K | |
| G0378 | Hospital observation service, per hour | <1% | 859 | $1K |
| 83735 | <1% | 4,194 | $1K | |
| 83880 | <1% | 1,681 | $966.40 | |
| 74018 | <1% | 14 | $898.54 | |
| 83690 | <1% | 3,186 | $816.80 | |
| 73110 | <1% | 14 | $656.71 | |
| 74019 | <1% | 39 | $620.89 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 26 | $531.76 |
| 73502 | <1% | 15 | $528.32 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 44 | $524.66 |
| 71250 | <1% | 14 | $481.96 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 89 | $442.38 |
| 36600 | <1% | 247 | $351.53 | |
| 87150 | <1% | 15 | $310.38 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 269 | $268.64 |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 985 | $252.13 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 358 | $197.05 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 379 | $188.32 |
| 76882 | <1% | 16 | $177.81 | |
| 84436 | <1% | 12 | $152.64 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 483 | $85.18 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 128 | $75.01 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,469 | $18.28 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,382 | $15.22 |
| 82247 | <1% | 31 | $12.94 | |
| 86140 | <1% | 27 | $8.54 | |
| 85651 | <1% | 110 | $4.66 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 93 | $2.80 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 459 | $0.23 |
| 82803 | 0% | 178 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 2,107 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 1,661 | $0.00 |
| 85730 | 0% | 1,733 | $0.00 | |
| 82553 | 0% | 463 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 559 | $0.00 |
| 82077 | 0% | 56 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 180 | $0.00 |
| 84075 | 0% | 29 | $0.00 | |
| 80320 | 0% | 202 | $0.00 | |
| 82150 | 0% | 98 | $0.00 | |
| 87205 | 0% | 60 | $0.00 | |
| 82040 | 0% | 30 | $0.00 | |
| 86901 | 0% | 12 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 36 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 13 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 38 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 494 | $0.00 |
| 82805 | 0% | 141 | $0.00 | |
| J0595 | Injection, butorphanol tartrate, 1 mg | 0% | 355 | $0.00 |
| T1015 | A visit at a community health center or clinic (one all-in rate) | 0% | 115 | $0.00 |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 0% | 26 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 52 | $0.00 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 18 | $0.00 |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 28 | $0.00 |
| 84450 | 0% | 30 | $0.00 | |
| 84155 | 0% | 31 | $0.00 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 42 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAE, KARYN (DIRECTOR)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.